Fresh analysis reveals that individuals who come off blockbuster slimming jabs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who end conventional diet and exercise programs.
Published data in a major health publication shows that while obese people often shed substantial amounts of their body weight while using the jabs, the mass is regained at an average rate of 0.8 kg per month after stopping.
"Users using these medications must be informed of the risk of quick rebound weight gain when the therapy concludes," stated expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to original weight in about a year and a half.
Comparing Therapies
The analysis, which reviewed 37 of trials involving thousands of patients, contrasted the effects of the injectable medications with older methods.
Scientists point out that individuals who lose weight through lifestyle changes alone typically experience a slower creep back—around 0.1 kg a month—post-intervention.
Explaining the Quick Rebound
Doctors propose the mode of action of the injections is key to understanding the amplified weight return.
GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate hunger.
"Long-term administration of the hormone concentrations several times higher than normal might result in the system to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication results in appetite is no longer kept in check, making binge eating far more likely."
An Ongoing Disease?
The NHS advise the jabs for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, given the likelihood of weight regain, the treatment should be considered life-long.
This perspective is echoed by pharmaceutical companies, who say that the results "emphasize the long-term nature of excess weight," similar to managing diseases like diabetes.
Patient Testimonies
People who have discontinued the medication report a powerful return of cravings.
"It felt as if a switch activating and you become extremely hungry," recalled a patient.
The struggle is exacerbated if users have not developed sustainable lifestyle or habit changes during therapy.
Significant Adoption
Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.
- Use is greater among females than males.
- The middle-aged age group shows the greatest level of interest.
- Many access the drugs through private healthcare rather than the NHS.
Finally, clinicians stress that while these medications are powerful agents for weight loss, they are not a standalone solution and lasting health benefits hinges on ongoing lifestyle support.
